Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16


Saturday night fever in ecstasy/MDMA dance clubbers: Heightened body temperature and associated psychobiological changes.

Parrott AC, Young L.

Temperature (Austin). 2014 Dec 10;1(3):214-9. doi: 10.4161/23328940.2014.977182. eCollection 2014 Oct-Dec.


Clinical applications of hallucinogens: A review.

Garcia-Romeu A, Kersgaard B, Addy PH.

Exp Clin Psychopharmacol. 2016 Aug;24(4):229-68. doi: 10.1037/pha0000084. Review.


Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective.

Kuypers KP, Theunissen EL, van Wel JH, de Sousa Fernandes Perna EB, Linssen A, Sambeth A, Schultz BG, Ramaekers JG.

PLoS One. 2016 Feb 23;11(2):e0149438. doi: 10.1371/journal.pone.0149438. eCollection 2016.


5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot Study.

Wright NE, Strong JA, Gilbart ER, Shollenbarger SG, Lisdahl KM.

PLoS One. 2015 Jul 31;10(7):e0134708. doi: 10.1371/journal.pone.0134708. eCollection 2015.


Ecstasy exposure & gender: examining components of verbal memory functioning.

Price JS, Shear P, Lisdahl KM.

PLoS One. 2014 Dec 29;9(12):e115645. doi: 10.1371/journal.pone.0115645. eCollection 2014.


The preclinical pharmacology of mephedrone; not just MDMA by another name.

Green AR, King MV, Shortall SE, Fone KC.

Br J Pharmacol. 2014 May;171(9):2251-68. doi: 10.1111/bph.12628. Review.


3,4-methylenedioxymethamphetamine (MDMA): current perspectives.

Meyer JS.

Subst Abuse Rehabil. 2013 Nov 21;4:83-99. doi: 10.2147/SAR.S37258. eCollection 2013. Review.


Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Watkins TJ, Raj V, Lee J, Dietrich MS, Cao A, Blackford JU, Salomon RM, Park S, Benningfield MM, Di Iorio CR, Cowan RL.

Psychopharmacology (Berl). 2013 May;227(1):41-54. doi: 10.1007/s00213-012-2936-1. Epub 2012 Dec 16.


Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R.

J Psychopharmacol. 2013 Jan;27(1):28-39. doi: 10.1177/0269881112456611. Epub 2012 Nov 20.


Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Di Iorio CR, Watkins TJ, Dietrich MS, Cao A, Blackford JU, Rogers B, Ansari MS, Baldwin RM, Li R, Kessler RM, Salomon RM, Benningfield M, Cowan RL.

Arch Gen Psychiatry. 2012 Apr;69(4):399-409. doi: 10.1001/archgenpsychiatry.2011.156. Epub 2011 Dec 5.


Prospective memory deficits in Ecstasy users: effects of longer ongoing task delay interval.

Weinborn M, Woods SP, Nulsen C, Park K.

J Clin Exp Neuropsychol. 2011 Dec;33(10):1119-28. doi: 10.1080/13803395.2011.614595. Epub 2011 Nov 3.


Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.

Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG Jr.

Addiction. 2011 Apr;106(4):777-86. doi: 10.1111/j.1360-0443.2010.03252.x. Epub 2011 Feb 15.


MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study.

Raj V, Liang HC, Woodward ND, Bauernfeind AL, Lee J, Dietrich MS, Park S, Cowan RL.

J Psychopharmacol. 2010 Feb;24(2):187-201. doi: 10.1177/0269881109103203. Epub 2009 Mar 20.


Neuroimaging in human MDMA (Ecstasy) users.

Cowan RL, Roberts DM, Joers JM.

Ann N Y Acad Sci. 2008 Oct;1139:291-8. doi: 10.1196/annals.1432.007.


Careers in ecstasy use: do ecstasy users cease of their own accord? Implications for intervention development.

Peters GJ, Kok G, Schaalma HP.

BMC Public Health. 2008 Oct 28;8:376. doi: 10.1186/1471-2458-8-376.

Supplemental Content

Support Center